Researchers identified a genetic mutation in the taurine transporter gene that prevents cats from absorbing taurine, an amino acid essential for heart health, even when eating nutritionally adequate diets. According to Gram Research analysis, this 2026 study found the c.1282C > T mutation in three domestic shorthair cats with dilated cardiomyopathy but absent in 422 control cats, representing the first genetic explanation for taurine deficiency in any domestic animal species.

Researchers discovered a genetic mutation in cats that prevents their bodies from absorbing taurine, an essential amino acid needed for heart health. The mutation was found in a family of domestic shorthair cats where multiple animals developed dilated cardiomyopathy (enlarged, weakened hearts) despite eating nutritionally balanced food with adequate taurine. This is the first genetic explanation for taurine deficiency in any domestic animal, opening new possibilities for understanding and preventing this serious heart condition in cats.

Key Statistics

A 2026 research article published in the Journal of Molecular and Cellular Cardiology identified a genetic mutation in the taurine transporter gene in three domestic shorthair cats with heart disease, with the mutation completely absent in 422 additional cats screened.

Laboratory testing showed that cells with the c.1282C > T mutation absorbed significantly less taurine and displayed reduced taurine transporter protein on their cell surface compared to cells with the normal gene.

This represents the first-ever reported genetic variant explaining taurine deficiency in any domestic animal species, according to researchers who conducted whole-genome sequencing on affected cats and healthy controls.

The Quick Take

  • What they studied: Why some cats develop heart disease from taurine deficiency even when eating proper diets, by examining the genes of affected cats
  • Who participated: Three domestic shorthair cats with taurine deficiency and heart problems, plus 18 healthy older cats (over 10 years old) as comparison group, and 422 additional cats screened for the mutation
  • Key finding: A single genetic mutation in the taurine transporter gene prevents cats’ cells from absorbing taurine properly, causing heart disease that can’t be fixed by diet alone
  • What it means for you: If your cat has unexplained heart disease despite good nutrition, a genetic test might identify this mutation. This discovery could lead to new treatments, though most cats won’t have this specific mutation

The Research Details

Scientists used whole-genome sequencing—reading an animal’s complete genetic code—to compare three sick cats with heart disease to 18 healthy older cats. They looked for genetic differences that might explain why the sick cats couldn’t use taurine properly. When they found a suspicious mutation in the taurine transporter gene, they tested it in 422 additional cats to confirm it was rare and specific to the affected family.

To prove the mutation actually caused the problem, researchers created cells in the laboratory with either the normal or mutated gene. They watched how well these cells could absorb taurine. The cells with the mutation absorbed much less taurine and showed less of the transport protein on their surface, confirming the mutation breaks the taurine absorption system.

This approach—combining genetic analysis with laboratory testing—is considered the gold standard for discovering new disease-causing mutations because it proves both that the mutation exists and that it actually causes the problem.

Previous research showed that cats need taurine from their diet because they can’t make enough themselves, unlike most other mammals. When cats don’t get enough taurine, they develop serious problems including heart disease, eye problems, and weak immune systems. However, some cats developed these problems even with adequate dietary taurine, suggesting a genetic cause. This study finally identified that genetic cause, which could explain similar cases in other cats and potentially other species.

This study is reliable because: (1) it used whole-genome sequencing, the most complete genetic analysis available; (2) the mutation was tested in a large population (422 cats) to confirm it’s rare; (3) laboratory experiments proved the mutation actually reduces taurine absorption; (4) the mutation pattern matched the inheritance pattern in the affected family. The main limitation is that this describes only one family, so the findings may not apply to all cats with heart disease.

What the Results Show

Researchers identified a specific genetic mutation (c.1282C > T) in the taurine transporter gene that prevents cats from absorbing taurine into their cells. This mutation was found in all three affected cats from the family but was completely absent in 18 healthy control cats and 422 additional cats screened, making it extremely rare and specific to this family.

When scientists tested the mutation in laboratory cells, cells with the mutated gene absorbed significantly less taurine compared to cells with the normal gene. Additionally, the mutated protein appeared less frequently on the cell surface, explaining why taurine couldn’t enter the cells efficiently. This functional defect directly caused the taurine deficiency observed in the affected cats.

The three affected cats showed a pattern consistent with incomplete dominance inheritance, meaning cats with one copy of the mutation had mild symptoms while the cat with two copies had severe heart disease. This inheritance pattern matched the genetic findings perfectly, strengthening the evidence that this mutation causes the disease.

Beyond the primary heart findings, the affected cats also showed other taurine deficiency symptoms including vomiting, loss of appetite, and lethargy. The severity of symptoms correlated with how many copies of the mutation each cat carried, with the most severely affected cat showing the most dramatic heart enlargement and dysfunction. These secondary symptoms resolved or improved when affected cats received taurine supplementation, confirming that the underlying problem was taurine deficiency rather than a primary heart defect.

This is the first time researchers have identified a genetic mutation causing taurine deficiency in any domestic animal species. Previous studies showed that taurine deficiency causes heart disease in cats, but the cause was always assumed to be dietary insufficiency. This discovery adds a new category: genetic inability to absorb taurine even when diet is adequate. The finding parallels human genetic diseases affecting nutrient transporters, suggesting similar mechanisms may exist in other species.

This study describes only one family of cats, so the findings may not apply to other cats with similar symptoms. The mutation is extremely rare, so it likely explains only a small percentage of heart disease cases in cats. The study doesn’t determine how common this mutation might be in cat populations worldwide or whether it occurs in other cat breeds. Additionally, the research was conducted in laboratory cells, not living cats, so real-world treatment responses may differ from predictions based on cellular studies.

The Bottom Line

According to Gram Research analysis, cats with unexplained heart disease should have their taurine levels checked, and genetic testing may be warranted if deficiency is confirmed despite adequate diet. Taurine supplementation remains the primary treatment. Breeders of domestic shorthair cats should consider genetic screening if this mutation appears in their lines. High confidence: taurine supplementation helps cats with this mutation. Moderate confidence: genetic testing will identify this specific mutation in other affected cats.

Cat owners whose cats have dilated cardiomyopathy despite proper nutrition should discuss genetic testing with their veterinarian. Breeders of domestic shorthair cats should be aware of this mutation’s existence. Veterinary cardiologists treating cats with unexplained heart disease should consider this genetic cause. This finding is less relevant for cats eating inadequate diets or those with other known causes of heart disease.

Cats with this mutation typically show symptoms within the first few years of life, as seen in the three-year-old cat in this study. Once identified and treated with taurine supplementation, some improvement in heart function may occur within weeks to months, though severe damage may be permanent. Genetic testing results are typically available within 1-2 weeks.

Frequently Asked Questions

Can cats with this taurine transporter mutation be treated?

Yes, taurine supplementation can help cats with this mutation absorb more taurine and improve heart function, though severe existing heart damage may be permanent. Treatment effectiveness depends on how early the condition is diagnosed and how much heart damage has already occurred.

How common is this genetic mutation in cats?

This mutation is extremely rare, found only in one family of domestic shorthair cats in this study and absent from 422 other cats screened. It likely explains only a small percentage of heart disease cases in cats overall.

Should I get my cat genetically tested for this mutation?

Genetic testing may be worthwhile if your cat has unexplained heart disease despite eating a nutritionally balanced diet with adequate taurine. Discuss testing options with your veterinarian, as this specific mutation is rare and other causes are more common.

What symptoms should I watch for if my cat might have this mutation?

Watch for vomiting, loss of appetite, lethargy, and signs of heart problems like difficulty breathing or exercise intolerance. These symptoms typically appear within the first few years of life and warrant immediate veterinary evaluation including heart ultrasound.

Can this mutation affect other cat breeds besides domestic shorthairs?

This study only examined domestic shorthair cats, so it’s unknown whether this specific mutation occurs in other breeds. However, similar genetic mutations affecting nutrient transporters exist across many species, so screening other breeds may be warranted.

Want to Apply This Research?

  • Track your cat’s taurine supplementation dosage and timing daily, plus monthly echocardiogram results or veterinary assessments of heart function to monitor disease progression or improvement
  • If your cat is diagnosed with this mutation, set daily reminders to administer taurine supplements at the same time each day, and schedule regular veterinary check-ups every 3-6 months to monitor heart function
  • Log taurine supplement administration, track any changes in symptoms (energy level, appetite, vomiting frequency), and maintain records of veterinary echocardiogram measurements to identify trends in heart size and function over time

This research describes a rare genetic mutation in cats and should not be used for self-diagnosis. If your cat shows signs of heart disease, vomiting, loss of appetite, or lethargy, consult your veterinarian immediately for proper evaluation and testing. Genetic testing for this specific mutation should only be performed under veterinary guidance. This article is for educational purposes and does not replace professional veterinary medical advice, diagnosis, or treatment. Always seek the advice of your veterinarian with any questions about your cat’s health or genetic testing options.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Whole-genome sequencing identifies a c.1282C > T missense variant in Taurine Transporter (TauT) associated with taurine-mediated dilated cardiomyopathy in a family of domestic shorthair cats. , Journal of molecular and cellular cardiology (2026). PubMed 42716424 | DOI
Topics
taurine deficiency cats dilated cardiomyopathy genetic cat heart disease mutation taurine transporter gene feline genetic disease SLC6A6 mutation cat nutrition genetics inherited heart disease cats